University of Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Chicago sits in the top decile of US sponsors by registered trial count (#41 of 15,742 sponsors by registered trial count).
University of Chicago: 796 sponsored US clinical trials, 158 recruiting.
University of Chicago sponsors 796 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 451 completed. 67 of these trials are in Phase 3-4 (later-stage) and 293 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 11 trials.
Top-decile sponsor footprint
University of Chicago ranks in the top decile of sponsors by registered trial count (#41 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
451 of 562 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
796 total, page 14 of 16
Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis
NCT00343850
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
NCT00347438
Psychotherapy for Intermittent Explosive Disorder
NCT00667212
Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis
NCT00361439
Comparison of Two Methods of Negative Pressure Wound Therapy
NCT00724750
Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of Illinois
NCT00817492
Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer
NCT00468169
N-Acetyl Cysteine in Trichotillomania
NCT00354770
Systemic Steroids Plus Antibiotics in Sleep Apnea Syndrome in Children
NCT00456339
N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence
NCT00332605
Effects of Continuous Airway Pressure on the Ability to Heat and Humidify Air
NCT00338403
The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
NCT00619242
Reducing the Risk of Developing Major Depression in Adolescents/Young Adults With Minor Depression/Depression Symptoms
NCT00145951
Cytokine Profiles in Children With Obstructive Sleep Apnea
NCT00456573
Trial of Adalimumab in Progressive Sarcoidosis
NCT00311246
Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies
NCT00943592
Early Indicators of Chronic Rejection in Lung Transplant
NCT00449332
Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors
NCT00708773
Efficacy of Naltrexone in Women's Smoking Cessation
NCT00271024
Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery
NCT00406913
Xolair in Patients With Chronic Sinusitis
NCT00117611
A Study to Tailor Advance Directives
NCT00121004
The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis
NCT00119015
Wireless Capsule Endoscopy in Ulcerative Colitis
NCT00145808
Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients
NCT01172470
Early Directed Physical Therapy in the Management of Mechanically Ventilated Patients in a Medical Intensive Care Unit
NCT00322010
Rapamycin in Advanced Cancers
NCT00707135
Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
NCT00143741
Follow-up at School-age of Children Who Participated in the Efficacy Study of Nitric Oxide for Premature Infants
NCT00152542
Impact of a Sleep Debt in Middle-Aged and Older Adults
NCT00817700
Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa
NCT00203957
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591
Nasal Ocular Reflexes Contribute to Eye Symptoms
NCT00117832
Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
NCT00519077
Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
NCT00203931
A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma
NCT00523640
Comparison Study Between Cefdinir & Amoxicilline/Clavulanate in Acute Sinusitis and Assessment of Quality of Life
NCT00147914
Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer
NCT01215500
A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations
NCT00116402
Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults
NCT00203853
Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)
NCT00117572
Study of Rapamycin Plus Ketoconazole in Advanced Cancers
NCT00708591
The Application of Neck Ultrasound in the Assessment of Peripherally Inserted Central Catheter (PICC) Tip Position
NCT00565877
Pediatric Sleep Questionnaire: Use for Collection of Clinical Data
NCT00203827
Pediatric Sleep Questionnaire: Normalization and Validation Study
NCT00203840
MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma
NCT00606866
A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer
NCT01187485
Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease
NCT00152620
Treatment for Chronic Depression
NCT00204152
A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment
NCT00145795
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 137 |
| Phase 2 | 156 |
| Phase 3 | 14 |
| Phase 4 | 53 |
Therapeutic Areas
What is open in the University of Chicago pipeline
158 recruiting of 796 indexed (20% open); 451 completed (57%).
Phase mix: 67 late (III/IV) vs 293 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Chicago: open-pipeline peers nationwide
Peers matched on 796 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 796 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
- University of Utah · 818 trials · 17% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this University of Chicago page
796 registered trials is a research-attention snapshot, not an endorsement of University of Chicago or any single study.
- 158 of University of Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Chicago pipeline card: 796 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.